Pelthos Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Pelthos Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Ticker symbol
- PTHS
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001919246
Board of directors
-
Andrew J. Einhorn · DirectorSince 2025
-
Chia-Lin Simmons · DirectorSince 2024
-
Ezra M. Friedberg · DirectorSince 2024
-
Matthew Pauls · DirectorSince 2025
-
Peter Greenleaf · DirectorSince 2025
-
Richard B. Baxter · DirectorSince 2025
-
Richard Malamut · DirectorSince 2024
-
Scott M. Plesha · Director · CEO and PresidentSince 2025
-
Todd C. Davis · DirectorSince 2024
Chief executives
Scott M. Plesha
· CEO and President
Since July 2025
Board connections
3 of this board's directors also sit on 4 other boards.
- via Matthew Pauls and Todd C. Davis
- via Peter Greenleaf
- via Todd C. Davis
- via Matthew Pauls
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $999,822
- 2 purchases by 1 insider
- Sold, last 12 months
- $441,348
- 21 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 2, 2026 | Ezra M. Friedberg Director | Open-market sale | −534 | $26.03 | $13,900 |
| Jul 2, 2026 | Peter Greenleaf Director | Open-market sale | −712 | $26.00 | $18,509 |
| Jul 2, 2026 | Matthew Pauls Director | Open-market sale | −692 | $26.00 | $17,989 |
| Jul 2, 2026 | Ezra M. Friedberg Director | Open-market sale | −24 | $27.33 | $656 |
| Jul 2, 2026 | Peter Greenleaf Director | Open-market sale | −85 | $27.27 | $2,318 |
| Jul 2, 2026 | Matthew Pauls Director | Open-market sale | −94 | $27.36 | $2,572 |
| Jun 15, 2026 | Ezra M. Friedberg Director | Open-market sale | −224 | $27.12 | $6,075 |
| Jun 15, 2026 | Ezra M. Friedberg Director | Open-market sale | −59 | $27.94 | $1,648 |
| Jun 11, 2026 | Todd C. Davis Director | Open-market purchase | +35,445 | $27.80 | $985,371 |
| Jun 11, 2026 | Todd C. Davis Director | Open-market purchase | +503 | $28.73 | $14,451 |
| May 22, 2026 | Knuettel Francis II Officer (CFO, Treas & Secty) | Sold back to the company | −13,947 | — | — |
| May 22, 2026 | Knuettel Francis II Officer (CFO, Treas & Secty) | Open-market sale | −1,500 | $26.84 | $40,260 |
| May 14, 2026 | Ezra M. Friedberg Director | Shares withheld for tax | −144 | $27.01 | $3,889 |
| Apr 2, 2026 | Richard Malamut Director | Open-market sale | −310 | $20.51 | $6,358 |
| Apr 2, 2026 | Ezra M. Friedberg Director | Open-market sale | −293 | $20.51 | $6,009 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.